I investigate the healthcare industry to reveal the trends and challenges shaping its future.

Medtronic Analyst Turns Bullish; Top 5 Upgrades for Tuesday

Marcus LeeTuesday, Mar 4, 2025 9:43 am ET

2min read

Medtronic, a leading medical device company, has seen a surge in analyst optimism, with several top firms upgrading their ratings and price targets. This positive sentiment is driven by the company's strong financial performance, innovative product pipeline, and expansion into high-growth markets. Here are the top 5 upgrades for Tuesday, highlighting the key factors that have analysts bullish on medtronic.

1. citigroup Upgrades Medtronic to 'Buy'
Citigroup analyst Joanne Wuensch upgraded Medtronic's rating from 'Neutral' to 'Buy' and raised the price target from $92 to $107. This upgrade reflects the analyst's positive outlook on the company's growth prospects, driven by strong revenue growth, improved gross and operating margins, and positive outlooks on key business segments such as Cardiac Rhythm Management, Structural Heart, Diabetes, and Neuromodulation.

2. Barclays Upgrades HSBC to 'Overweight'
Barclays analyst Aman Rakkar upgraded HSBC Holdings plc's rating from 'Equal-Weight' to 'Overweight.' This upgrade is based on the analyst's positive outlook on the banking sector and HSBC's strong performance in the face of challenging market conditions.

HSBC Total Revenue year-on-year growth value, Basic EPS...

Name
Date
Total Revenue year-on-year growth value
Basic EPS(USD)
ROE(Average)%

Hsbc HoldingsHSBC

20241231

-1.79B

0.01

12.38

Comments

Post

DumbStocker

03/04

$C 300% up

HairyBallsOfTheGods

$MDT Speculating on Geoff Martha's departure this month. For a friend.

LurkerMcLurkington

MedtroniC's margins rock, Citigroup nailed it with 'Buy'.

Mojojojo3030

Medtronic's innovation in structural heart is a game-changer. Analysts see growth; I see potential for a moonshot. 🚀

Neyo_708

Holding $MDT long-term. Neuromodulation market's expanding. Diversifying my portfolio with healthcare giants. Safe and promising play.

EL-Vinci93

Neuromodulation growth is insane, bullish on innovation.

girldadx4

Holding $MDT long-term, diabetes segment's a game-changer.

Local-Store-491

@girldadx4 How long you been holding MDT? Curious about your experience with the diabetes segment.

wodentx

Barclays calls, but will $HSBC really deliver? 🤔

racoontosser

Strong buy ratings rolling in. Medtronic's growth story is solid, but I'm hedging with some $AAPL on the side.

Ok-Swimmer-2634

Strong earnings last quarter set the stage. Expecting more positive surprises. Anyone else riding this wave or waiting for dips?

Stevitop

@Ok-Swimmer-2634 Riding it, but watching fundamentals.

JobuJabroni

@Ok-Swimmer-2634 What's your take on Q4?

infinitycurvature

Barclays upgrading HSBC? Not surprised. They're weathering storms like champs. Banking sector's resilience never hurts.

Free-Initiative7508

Medtronic's pipeline is fire. Analysts catching on, but don't sleep on potential volatility in the healthcare sector.

Buffet_fromTemu

Citigroup's call got me pumped. Medtronic's margins and product pipeline make it a solid play. Time to load up before Q1 earnings.

Dan wood

I was once a victim of scam and with the help of Rapidrestore I was able to get my losted funds $85k back , Even if you lose money to an investment broker don’t go down without a fight . I was naive for thinking it wasn't possible to recover my money from a greedy broker but everything turns out to be legit after I came across a review here testifying about Rapidrestore ,indeed Rapidrestore are 100% sure in restoring back losted funds . Contact them .

Telegram ; Rapidrestore

WhatsApp : +1 785 304 8110‬.

WinningWatchlist

@Dan wood 👌

throwaway0203949

Strong earnings boost, Medtronic's pipeline is fire.

vanilica00

@throwaway0203949 Medtronic's pipeline looks solid, but let's see if they can deliver.